When considering any new medication, safety is the first and most important question. For patients in Penarth exploring weight loss injections, understanding how Mounjaro works, who it is suitable for, and what precautions are in place is just as important as knowing what results to expect.
The good news is that Mounjaro (tirzepatide) has been through rigorous clinical testing and is a licensed medication in the UK. That said, like all prescription treatments, it is not suitable for everyone, and proper assessment before starting is essential.
If you would like to find out whether Mounjaro could be right for you, get in touch with our team at info@mayberrypharmacy.co.uk or book a consultation online today.
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It works by mimicking two hormones, GIP and GLP-1, involved in appetite regulation and blood sugar control. By activating both pathways, it helps reduce hunger, slow the rate at which food leaves the stomach, and support the body in managing glucose more effectively.
It is administered once weekly via a pre-filled injection pen, with doses gradually increased over time to support tolerability. Mounjaro is a prescription-only medication and should always be used under the supervision of a qualified healthcare professional.

Yes. Mounjaro received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK as a treatment for weight management in adults. It is prescribed alongside a reduced-calorie diet and increased physical activity.
The approval was based on data from the SURMOUNT clinical trial programme, one of the largest and most comprehensive weight management trial programmes conducted to date. The trials demonstrated both meaningful weight loss outcomes and an acceptable safety profile across large patient populations.
Before any prescription is issued, a thorough consultation is carried out to confirm suitability. NHS states that Mounjaro may be appropriate for adults who meet the following criteria:
Our pharmacists take your full medical history into account before any prescription is issued, ensuring the treatment is appropriate for your individual circumstances.
There are certain groups for whom Mounjaro is not recommended. These include:
This is not an exhaustive list. A full clinical assessment during your consultation will identify any contraindications relevant to your personal health history.
As with all medications, Mounjaro can cause side effects. The most commonly reported ones are gastrointestinal and tend to be most noticeable during the early weeks of treatment as the body adjusts. These may include:
| Side Effect | How Common | Typically Resolves |
|---|---|---|
| Nausea | Very common | Usually, within a few weeks |
| Diarrhoea | Very common | Usually, within a few weeks |
| Vomiting | Common | Typically settles with dose adjustment |
| Constipation | Common | Usually improves over time |
| Reduced appetite | Very common | Ongoing (intended effect) |
| Injection site reactions | Common | Usually mild and short-lived |
Starting on the lowest dose and increasing gradually helps to minimise these effects. If side effects feel severe, persistent, or concerning, always contact a healthcare professional promptly.
Understanding the factors that influence your results helps you go into treatment with realistic, well-informed expectations.
Consistency matters. Taking your injection on the same day each week and following your prescribed dose schedule gives the medication the best opportunity to work effectively.
Mounjaro reduces appetite, which makes eating less easier. However, the nutritional quality of what you do eat still influences outcomes. A diet rich in protein, fibre, and whole foods supports better long-term results.
Exercise supports weight loss, helps preserve lean muscle mass, and improves cardiovascular health alongside treatment. It does not need to be intense to be beneficial.
Certain conditions, including hypothyroidism or polycystic ovary syndrome (PCOS), can affect how the body responds to weight loss treatment. These do not necessarily prevent treatment but should be disclosed and monitored during your consultations.
Patients who are able to progress through the dose schedule tend to see stronger results over time. Your prescriber will support you with this at each review.
For more on how and when results typically develop during treatment, our guide on Mounjaro before and after covers what patients commonly experience at different stages of their journey. If you have concerns about progress at any point, our blog on not losing weight on Mounjaro explores the most common reasons and what can be done.

Clinical trial data covering up to 72 weeks support the safety of Mounjaro for extended use when monitored appropriately. As with any long-term medication, regular reviews with your prescriber are important.
Mounjaro can affect the absorption of oral medications by slowing gastric emptying. It is important to disclose all current medications during your consultation, so any potential interactions can be assessed.
Yes. Our Penarth branch offers private Mounjaro prescriptions and ongoing support. Online booking is also available for your convenience.
No referral is needed. You can book a private consultation directly with our team, and we will carry out a full suitability assessment before any prescription is issued.
If you experience severe abdominal pain, signs of an allergic reaction, or any symptom that feels serious, seek medical attention promptly. Do not wait for your next scheduled appointment.
Safety is not just a feature of the medication itself. It also comes from having the right support around you throughout treatment. At Mayberry Pharmacy, every patient receives a thorough assessment before starting, regular check-ins during treatment, and open access to advice whenever it is needed.
We serve patients across South Wales from our branches in Penarth, Newport, Caerphilly, Pontypool, Crumlin, and Blackwood.
Contact us at info@mayberrypharmacy.co.uk or book your weight loss consultation online today.